Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2017-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1060028016686106PMID 28056524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duration of anticoagulation after venous thromboembolism in real world clinical practice.

  2015cited by this paper
• Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration

  2014cited by this paper
• Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Warfarin Therapy in the HIV Medical Home Model: Low Rates of Therapeutic Anticoagulation Despite Adherence and Differences in Dosing Based on Specific Antiretrovirals

  2012cited by this paper
• Aspirin for preventing the recurrence of venous thromboembolism.

  2012cited by this paper
• Low-dose aspirin for preventing recurrent venous thromboembolism.

  2012cited by this paper
• Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

  2012cited by this paper
• Performance outcomes of a pharmacist‐managed anticoagulation clinic in the rural, resource‐constrained setting of Eldoret, Kenya

  2011cited by this paper
• Mediterranean Journal of Hematology and Infectious Diseases Hiv-associated Venous Thromboembolism

  2011influential reference
• Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting

  2011cited by this paper
• Risk Factors for Venous Thromboembolism in Patients with Human Immunodeficiency Virus Infection

  2010influential reference
• Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era

  2008influential reference
• Determinants and measures of quality in oral anticoagulation therapy

  2008cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Responding to the HIV pandemic: the power of an academic medical partnership.

  2007cited by this paper
• Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

  2006cited by this paper
• Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons: Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras

  2006cited by this paper
• Is chronic HIV infection associated with venous thrombotic disease? A systematic review.

  2005cited by this paper
• Epidemiology of thrombosis in HIV-infected individuals

  2000cited by this paper
• Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project.

  2000cited by this paper
• A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

  1993cited by this paper

• Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors

  2025cites this paper
• Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United States

  2023cites this paper
• Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy

  2022cites this paper
• International Normalized Ratio (INR) Increases amongst Two Patients Living with HIV on Warfarin after Being Switched from a Nevirapine to a Dolutegravir-Based Antiretroviral Regimen

  2021cites this paper
• Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes

  2021cites this paper
• Evaluating the impact of a 15-year academic partnership to promote sustainable engagement, education, and scholarship in global health

  2020cites this paper
• Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya

  2020cites this paper
• Improving anticoagulation in sub‐Saharan Africa: What are the challenges and how can we overcome them?

  2020cites this paper
• The Genetics of Warfarin Dose–Response Variability in Africans: An Expert Perspective on Past, Present, and Future

  2019cites this paper
• Manifestations thromboemboliques chez 36 patients Ouest Africains infectés par le VIH

  2018influential citation